公开(公告)号：NZ745920A

公开(公告)日：2020-01-31

申请号：NZ74592014

申请日：2014-04-18

Applicant: OCULEVE INC

Inventor： ACKERMANN DOUGLAS ,  LOUDIN JAMES ,  WARDLE JOHN ,  BALDWIN JARREN ,  HAMILTON DANIEL ,  KUZMA JANUSZ ,  STIVERS CHRISTOPHER

IPC: A61N1/18 ,  A61N1/30 ,  A61N1/36 ,  A61N1/372

Abstract: A system or device for stimulating nasal tissue of a subject, comprising: a stimulator comprising a stimulator probe comprising a nasal insertion prong; and a handheld stimulator body comprising a rechargeable power source and a control subsystem to control a stimulus to be delivered to the subject via the nasal insertion prong; and a base station to recharge the rechargeable power source, comprising one or more electrical contacts configured to connect to the stimulator body, wherein the stimulator probe is releasably connected to the stimulator body, and wherein the stimulator comprises a disabling mechanism that prevents stimulus delivery to the subject after at least one of a predetermined time from attachment of the stimulator probe, a predetermined number of treatment sessions, a predetermined duration of stimulus delivery, or reconnection of the stimulator probe to the stimulator body after being disconnected from the stimulator body. The disabling configuration prevents re-use of probes that may be unsanitary.

公开(公告)号：NZ704579A

公开(公告)日：2018-10-26

申请号：NZ70457914

申请日：2014-04-18

Applicant: OCULEVE INC

Inventor： ACKERMANN DOUGLAS ,  LOUDIN JAMES ,  WARDLE JOHN ,  BALDWIN JARREN ,  HAMILTON DANIEL ,  KUZMA JANUSZ ,  STIVERS CHRISTOPHER

IPC: A61N1/18 ,  A61N1/30 ,  A61N1/36 ,  A61N1/372

Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.